Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
about
Blood pressure control for diabetic retinopathyEpidemiological issues in diabetic retinopathyShort Pulse Duration High-Power Laser Photocoagulation during Vitrectomy for Diabetic Retinopathy Reduces Postoperative InflammationAfrican Ancestry Analysis and Admixture Genetic Mapping for Proliferative Diabetic Retinopathy in African Americans.Does tight control of systemic factors help in the management of diabetic retinopathy?Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathyDyslipidemia and eye diseases in the adult Chinese population: the Beijing eye studyAge-related alterations in retinal neurovascular and inflammatory transcriptsDiabetic retinopathy in Victoria, Australia: the Visual Impairment ProjectDiabetic retinopathy: an updateEffects of medical therapies on retinopathy progression in type 2 diabetesPrevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study.Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.Age at onset and the risk of proliferative retinopathy in type 1 diabetesChronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome.Risk factors for proliferative diabetic retinopathy in a Latino American population.The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation.The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?Anaemia, haemoglobin level and cause-specific mortality in people with and without diabetes.Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy.Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management.Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetesDiabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic.Diabetic retinopathy - An update.Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study.Renal function but not asymmetric dimethylarginine is independently associated with retinopathy in type 2 diabetesMicroalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy.Neurovascular interaction and the pathophysiology of diabetic retinopathyAssociation of systemic and ocular risk factors with neurosensory retinal detachment in diabetic macular edema: a case-control studyA new colour vision arrangement test to detect functional changes in diabetic macular oedema.Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans.Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathyAssociation of retinopathy and intima media thickness of common carotid artery in type 2 diabetic patientsStreptozotocin-induced diabetes modulates GABA receptor activity of rat retinal neurons.Retinal blood flow is increased in type 1 diabetes mellitus patients with advanced stages of retinopathySub-threshold micro-pulse diode laser treatment in diabetic macular edema: A Meta-analysis of randomized controlled trials.Factors associated with diabetic retinopathy in chinese patients with type 2 diabetes mellitus.Predictors for diabetic retinopathy in normoalbuminuric people with type 2 diabetes mellitus
P2860
Q24186434-0CF75A9A-81F7-4671-A52E-0DFAA090A126Q27003941-03B25C74-6EE1-46A1-BA14-86E2F1345482Q27300854-FBB90014-84BE-41A1-ADB5-426832C65F78Q27334828-2AB045CB-0CE4-4D90-8F7F-363187A8CDEBQ28074223-AF7234CC-0DDD-4C8D-BDC5-9E8B235BB1ADQ28476732-4BC4E186-DA7F-44C2-A0B1-5D6BD5BA4748Q28482265-F09C69CB-06E0-4029-B840-E82CC5B02E51Q28570411-1F00A949-527F-42EF-B477-99FB18F3145AQ31793083-F54402C8-B978-49C8-91B7-4F31C348C8F2Q33328784-B34028CE-F857-4F09-844E-6F8A96DEE1FAQ33620031-F2FAF3E8-C6A7-49A9-8EB9-02974786FC42Q33812061-27C629F4-B51D-4C3C-8034-A250714849E2Q33855386-4DB73F48-CCCA-47AF-8AC4-215DB07D2137Q33873142-DF1BDC60-E82D-4582-A2EA-AA1608B232C2Q33901377-D284EB4E-0740-4781-A459-D9A278D9D149Q33946519-4C5C6BC8-8052-4F23-AF86-84D17A2D141FQ33972545-05CC5433-4C99-4B85-8BA3-AA6D6190ABEAQ34123557-4FFE5EF7-608C-4AAB-8672-42DFD712C623Q34261308-9C374ED0-9421-4EFA-B5C0-F6ABA4E57A1BQ34372505-1BB32815-C905-416B-9719-392B8D81A406Q34442253-ECE378D9-D1E8-4679-A348-09722572AB6BQ34560674-ABCBC4C5-E490-41C9-98F0-BC61846E9889Q34645677-47D330FA-2005-497C-A7BE-1A1128D6E804Q34790721-E1A20A5F-97F7-4CE1-A439-FD0C1A4AF976Q34957902-B25E4107-7BDA-4256-993E-BB8244056654Q34986774-001C231B-14F4-404E-B2D9-A443DE714FC9Q34996442-108B66DD-6498-4F73-83C9-B74EEF59D9D7Q35060372-E5B03353-6D5A-485C-ABBD-B1991CDAC5FBQ35071239-C6AC214F-5D31-46C4-9C38-C75776841AB4Q35143468-1267545C-F512-47C2-B6B8-A38495164240Q35317086-4E66A380-5606-4198-871E-F6CC852BA729Q35571714-8F07E866-57DB-4D90-879B-D90C183D172BQ35589517-6FAD71E3-6FD3-40B7-8AAC-17B032E2FBD6Q35608796-C7FB60ED-98FE-4F7F-BE7A-D0A873A9930BQ35745320-25345327-59D7-4B89-BA95-1C3C18FBB1A5Q36026702-ED6FEF06-1C9A-42D7-9109-F305E5291C8FQ36031668-7A972E29-44D6-4330-9352-FA614B0359B8Q36097239-7D1C2EEC-EB0D-47A3-BC53-DA2982CEF806Q36104391-6C51A30F-0EE8-4962-B000-CF4F516154BEQ36125538-5CBE2F7E-48F0-4652-A5AA-A3E36E24DAEF
P2860
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Risk factors for high-risk pro ...... Retinopathy Study Report #18.
@ast
Risk factors for high-risk pro ...... Retinopathy Study Report #18.
@en
type
label
Risk factors for high-risk pro ...... Retinopathy Study Report #18.
@ast
Risk factors for high-risk pro ...... Retinopathy Study Report #18.
@en
prefLabel
Risk factors for high-risk pro ...... Retinopathy Study Report #18.
@ast
Risk factors for high-risk pro ...... Retinopathy Study Report #18.
@en
P2093
P1476
Risk factors for high-risk pro ...... Retinopathy Study Report #18.
@en
P2093
F L Ferris
G L Knatterud
L M Aiello
M R Fisher
R E Gangnon
P304
P407
P577
1998-02-01T00:00:00Z